167 related articles for article (PubMed ID: 14638550)
1. Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5.
Abramowitz J; Dai C; Hirschi KK; Dmitrieva RI; Doris PA; Liu L; Allen JC
Circulation; 2003 Dec; 108(24):3048-53. PubMed ID: 14638550
[TBL] [Abstract][Full Text] [Related]
2. Low concentrations of ouabain induce vascular smooth muscle cell proliferation.
Aydemir-Koksoy A; Allen JC
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):341-5. PubMed ID: 11355010
[TBL] [Abstract][Full Text] [Related]
3. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
Oselkin M; Tian D; Bergold PJ
Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
[TBL] [Abstract][Full Text] [Related]
4. Endogenous cardiotonic steroids.
Schoner W
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
[TBL] [Abstract][Full Text] [Related]
5. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
Bagrov AY; Fedorova OV
J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
[TBL] [Abstract][Full Text] [Related]
6. Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells.
Uddin MN; Horvat D; Glaser SS; Danchuk S; Mitchell BM; Sullivan DE; Morris CA; Puschett JB
Placenta; 2008 Mar; 29(3):266-73. PubMed ID: 18279954
[TBL] [Abstract][Full Text] [Related]
7. Interaction between Na+/K+-pump and Na+/Ca2+-exchanger modulates intercellular communication.
Matchkov VV; Gustafsson H; Rahman A; Briggs Boedtkjer DM; Gorintin S; Hansen AK; Bouzinova EV; Praetorius HA; Aalkjaer C; Nilsson H
Circ Res; 2007 Apr; 100(7):1026-35. PubMed ID: 17347477
[TBL] [Abstract][Full Text] [Related]
8. Role of low ouabain-sensitive isoform of Na+-K+-ATPase in the regulation of basal tone and agonist-induced contractility in ovine pulmonary artery.
Chanda D; Krishna AV; Gupta PK; Singh TU; Prakash VR; Sharma B; Joshi P; Mishra SK
J Cardiovasc Pharmacol; 2008 Aug; 52(2):167-75. PubMed ID: 18670362
[TBL] [Abstract][Full Text] [Related]
9. Role of caveolae in ouabain-induced proliferation of cultured vascular smooth muscle cells of the synthetic phenotype.
Liu L; Abramowitz J; Askari A; Allen JC
Am J Physiol Heart Circ Physiol; 2004 Nov; 287(5):H2173-82. PubMed ID: 15256370
[TBL] [Abstract][Full Text] [Related]
10. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY
J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
[TBL] [Abstract][Full Text] [Related]
11. Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.
Bagrov AY; Roukoyatkina NI; Pinaev AG; Dmitrieva RI; Fedorova OV
Eur J Pharmacol; 1995 Feb; 274(1-3):151-8. PubMed ID: 7768267
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
Fedorova OV; Bagrov AY
Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
[TBL] [Abstract][Full Text] [Related]
13. Low concentrations of ouabain activate vascular smooth muscle cell proliferation.
Allen JC; Abramowitz J; Koksoy A
Ann N Y Acad Sci; 2003 Apr; 986():504-8. PubMed ID: 12763871
[TBL] [Abstract][Full Text] [Related]
14. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Na+,K+ pump affects nucleic acid synthesis and smooth muscle cell proliferation via elevation of the [Na+]i/[K+]i ratio: possible implication in vascular remodelling.
Orlov SN; Taurin S; Tremblay J; Hamet P
J Hypertens; 2001 Sep; 19(9):1559-65. PubMed ID: 11564975
[TBL] [Abstract][Full Text] [Related]
16. Ral-GTPase interacts with the beta1 subunit of Na+/K+-ATPase and is activated upon inhibition of the Na+/K+ pump.
Bhullar RP; Clough RR; Kanungo J; Elsaraj SM; Grujic O
Can J Physiol Pharmacol; 2007; 85(3-4):444-54. PubMed ID: 17612654
[TBL] [Abstract][Full Text] [Related]
17. The death of ouabain-treated renal epithelial cells: evidence against anoikis occurrence.
Akimova OA; Poirier M; Kotelevtsev SV; Hamet P; Orlov SN
Apoptosis; 2008 May; 13(5):670-80. PubMed ID: 18392681
[TBL] [Abstract][Full Text] [Related]
18. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
Schoner W; Scheiner-Bobis G
Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
[TBL] [Abstract][Full Text] [Related]
19. Decreased contraction to phenylephrine by ouabain in 2K-1C rat aorta is modulated by the endothelium.
Molin JC; Sguilla FS; Bendhack LM
Eur J Pharmacol; 2005 Oct; 522(1-3):94-9. PubMed ID: 16188252
[TBL] [Abstract][Full Text] [Related]
20. Selective ligands for Na
Chakraborty D; Fedorova OV; Bagrov AY; Kaphzan H
Neuropharmacology; 2017 May; 117():338-351. PubMed ID: 28232062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
